Abstract 26
The supplementation of foods with biologically active compounds can be a powerful approach for 27 improving diet and well being. In this study we separately included into pasta matrices a 28 concentrate of γ-conglutin, a glucose-lowering protein from Lupinus albus seeds, an isolate of the 29 other main lupin storage proteins and ovalbumin, with a ratio corresponding to 125 mg of pure 30 protein in 100 g of pasta. With these products we fed rats made hyperglycaemic for 3 weeks. 31
Among the most relevant changes measured in body and blood parameters were: i. a significant 32 reduction of food intake of rats fed γ-conglutin concentrate supplemented pasta and a significant 33 limitation in the body weight increase in rats fed α, β and δ-conglutins isolate supplemented pasta, 34 while the food conversion indexes were unchanged; ii. a reduction of glycaemia upon glucose 35 overload trial, especially in the γ-conglutin concentrate supplemented pasta fed animals at a dose of 36 45 mg/kg body weight. The correlations among the measured parameters are discussed. Overall, the 37 results evidence the potentiality of supplementing traditional foods with exogenous nutraceutical 38 seed proteins to control body weight gain and glycaemia. 
Introduction 49
The role of foods and food components on the prevention and control of several diseases is 50 increasingly been acknowledged worldwide. Therefore, the need of improving the 51 nutritional/nutraceutical performance of foods to control expanding syndromes, such as diabetes, 52 obesity, metabolic syndrome, overweight conditions and others, is crucial. One of the possible ways 53 is the supplementation of traditional foods with biologically active compounds. However, effective 54 examples in this area are not frequent and often technological/functional problems related to 55 stability, efficiency, dosage of the compounds and their sensorial effects on foods prevent the 56 implementation of potentially relevant formulas. 57
Nowadays, a critical sanitary area is the control of diabetes and obesity, which are already a 58 public health emergency for their increasing incidence and prevalence throughout the world.
1 In this 59 respect, the kinetics of glucose release and absorption after food ingestion and the resulting effects 60 on the synthesis of and sensitivity to insulin, as well as the regulation of satiety, are gaining interest 61 for the prevention of diabetes and obesity. 62
Lupin seeds and flours are among the natural foods which have been claimed to have anti-63 diabetic properties by the traditional medicine. As a matter of facts, the active principle responsible 64 of the glucose-lowering activity has unequivocally been identified in the protein γ-conglutin, that in 65
Lupinus albus seeds constitutes about 5% of total seed proteins, corresponding to about 2 g of γ-66 conglutin in 100 g of dry seeds or flour. Significant variations of γ-conglutin content amongst L. 67 albus varieties have not been reported so far. Not only has this lupin protein repeatedly been shown 68 to decrease glycaemia in animals and humans, 2,3 but its interaction with the putative target cells, 69 including myocytes and hepatocytes, 4,5 proved to produce a number of effects which have 70 collectively been classified as insulin-mimetic activity. Despite this potentiality, no study on the 71 effects of γ-conglutin incorporated into a food matrix has been undertaken so far. 72
Pasta is a traditional food which, for many structural and technological reasons, can be 73 considered an effective vehicle of bioactive proteins and peptides. Consequently, we have prepared 74 pasta samples supplemented with a γ-conglutin concentrate or the remnant main lupin seed proteins 75 isolate as well as with ovalbumin, as a control. With these samples, we have fed rats for three weeks 76 and measured various body and blood parameters. 77
1 Materials 83
White lupin seeds (Lupinus albus, var. Multitalia) were a kind gift of Agroservice S.p.A., Rocchetta, 84
San Severino Marche, Italy. 85
Ovalbumin was purchased from Sigma Aldrich (Milan, Italy). 86
Chemicals were all reagent grade by Sigma Aldrich (Milan, Italy), unless specified otherwise. 87 88
Lupin proteins fractionation 89
Mature dry seeds of Lupinus albus, L. were used as a source of the protein fractions. Lupin proteins 90 were fractionated as described by Sironi with some minor modifications. 6 Briefly, the seeds were 91 milled to a flour which was sieved through a 80 mesh sieve. The proteins in the flour were extracted 92 with distilled water containing 0.5 M NaCl in the ratio 1/10 w/v at 4°C for 3 hours. The pH was 93 constantly kept between 7.0 to 9.0 by the addition of 0.1 M NaOH. The slurry was centrifuged at 94 10,000 x g at 4 °C for 30 min. The supernatant was adjusted to pH 4.5-5.5 with acetic acid for 95 protein isoelectric precipitation. The resulting suspension was centrifuged as above. The pellet was 96 washed twice with distilled water at pH around 5.0. The washed pellet was then freeze dried. This 97 fraction consisted of the isoelectrically-precipitated main lupin proteins. The fraction soluble at pH 98 5.0 was adjusted to pH 7.0 with 0.1 M NaOH and 20 mM ZnCl 2 was added. The resulting 99 suspension was centrifuged as above and the pellet recovered. The pellet was washed twice with 100 distilled water and freeze dried. As it will be seen below, this fraction mainly consisted of γ-101 conglutin. 102 103
SDS-PAGE of the protein fractions 104
The protein samples were suspended in the sample buffer in the ratio 1:20 (w/v). The sample buffer 105 consisted of 0.25 M Tris-HCl, pH 6.8, 7.5 mL/100 mL glycerol, 20 mg/mL SDS and 2.5 mL/100 106 mL 2-mercaptoethanol. After heating at 100°C for 5 min, each sample was loaded on the gel. SDS-107 PAGE was carried out on 7 x 8 cm 12% polyacrylamide gels, using a mini-Protean III cell (Bio-108 Rad). The gels were stained with Coomassie blue. 7 The gels were digitalised in an Epson Perfection 109 V500 Scanner and analysed with ImageMaster 1-D Elite Software (GE Healthcare, Milan, Italy). 110 111
Western blotting 112
The proteins in gels were transferred to 0.45µ-pore nitrocellulose membranes (Protran, 110
Pasta preparation and protein inclusion 118
Pasta supplied to the animals was a mix of commercial dry pasta and dry test pasta, including 119 selected protein fractions from lupin seed and ovalbumin, as the control. Test pasta containing γ-120 conglutin concentrate was mixed with commercial pasta in a 1/4 ratio (w/w); α+β+δ-conglutins 121 isolate and ovalbumin containing pasta were mixed with commercial pasta in a 1/8 ratio (w/w). All 122 pasta samples were uncooked to allow easy grinding to a fine powder. 123
Test pasta was prepared according to standard protocols. Durum wheat semolina of good 124 pasta-making performances (protein: 14.3 g/100g db; dried gluten: 13.2g/100 g) was supplied by 125
Molino Grassi (Parma, Italy). Semolina and protein fractions (1g/100g semolina and 1g/100g each 126 lupin protein fraction and commercial ovalbumin) were mixed with water (kept at 40°C) to produce 127 a mixture with a final moisture of 34%. After mixing for 10 minutes, each blend was extruded and 128 formed into macaroni shape (7 mm external diameter) using a continuous pilot-scale plant (20 kg/h; 129 MAC 30, Italpast, Parma, Italy). Fresh pasta was finally dried in a pilot-scale drier (50 kg/h, 130
Braibanti, Milan, Italy) using a low-temperature drying cycle (50°C max for 14h), according to 131
Marti, Seetharaman and Pagani. 
Chronic treatment with test pasta 145
Test diet consisted of the above mentioned diet (adaptation diet) with the substitution of part of 146 commercial pasta with a corresponding amount of test pasta samples. The animals (24) were 147 divided into 3 homogenous groups, according to their blood glucose concentration. The animals 148
were fed ad libitum with a diet containing pasta supplemented with lupin γ-conglutin concentrate,was freely available. Every day the food intake and the body weight of each animal were measured. 151
At the end of the experimental period, the animals were fasted for 12 hours, sacrificed, and the 152 blood was collected for the determination of glycaemia, insulin and other hormone concentrations. 153 154
Acute treatment with test pasta (Glucose Overload Trial) 155
At the end of the adaptation period, 24 untreated animals were divided into 3 homogenous groups, 156 according to their blood glucose concentration. The animals were fasted for 20 hours. Then, 10 g of 157 γ-conglutin, α+β+δ-conglutins and ovalbumin supplemented pasta samples were supplied to the 158 animals, which entirely ate within 30 minutes. Immediately after this meal, 2 g/kg of D-glucose 159 were administered to the animals by gavage. Before the meal and 30-60-90-120 minutes after 160 glucose administration, blood glucose was determined. 161 162
Blood analysis 163
Glucose concentrations were measured using a kit, based on an enzymatic method of detection, 164 purchased from R-Biopharm (Germany). Insulin, leptin and total ghrelin were assayed using ELISA Analysis of variance was carried out on the data collected by using the above cited software. 178
The Bonferroni test was used to compare the means. The differences were considered 179 significant at P<0.05. The relationships between variables was determined by means of Pearson's 180 correlation coefficient, using the software PROC CORR of SAS 9.2. 181
The two isolated lupin protein fractions and ovalbumin, which were included in the test pasta dough 185 at a dose of 1g/100g, were submitted to SDS-PAGE under reducing conditions and the resulting 186 profiles are shown in Figure 1 . By comparing the electrophoretic patterns with the γ-conglutin and 187 total proteins extract references and on the basis of previous separations and mass spectrometry 188 analysis, 11 it was concluded that the lane B of Fig. 1 contained primarily γ- The rat initial weights did not differ in the three groups, while differences were marked at 208 the end of the 3 weeks trial: in particular a lower body weight was reached by rats fed α, β and δ-209 conglutins isolate compared to animals fed the ovalbumin supplemented pasta. The food intake of 210 rats fed γ-conglutin concentrate supplemented pasta was also remarkably and significantly lower 211 than that observed with ovalbumin supplemented pasta. 212
The constancy of the conversion index (CI) for all samples suggested a similar efficiency of 213 the three groups in converting food to energy. 214 Table 2 reports the fasting glycaemia levels observed at the beginning and the end of the 215 At the end of the treatment, no statistically significant changes of hormone levels between 218 the lupin protein supplemented pasta and the ovalbumin supplemented pasta were monitored (Table  219 2), also due to the great variability. 220 221
Correlations between the measured parameters 222
All the measured parameters have been correlated by using the Pearson correlation coefficient in 223 order to investigate the possible inter-dependences, as described under Methods and shown in Table  224 3. 225
After the chronic treatment, blood glucose, food intake, growth and leptin blood level of 226 treated animals positively correlated: higher food intake induced higher growth and glycaemia; 227 leptin is produced by adipose tissue, therefore higher growth induced higher release of leptin. 228
Leptin and insulin also positively correlated, according to Amitani, Asakawa, Haruka, and Inui. 13 In 229 our experiment both hormones were directly related and this could be due to the positive 230 relationship between insulin and live weight. Since leptin is related to body weight, we could 231 hypothesize that heavier animals have higher concentrations of insulin and leptin. Anyway the 232 positive relationship between insulin and leptin observed in our experiment is a quite common 233 finding. 14 
234
The interpretation of the positive relationship between ghrelin and leptin is more complex. 
Glucose overload trial with test pasta samples 240
The animals (24) fed the adaptation diet for one week to induce hyperglycemia and fasted for 20 241 hours were submitted to glucose overload trial. During the 20 hour fasting, rats were allowed to 242 drink tap water with no glucose added. Then, as detailed under Methods, 10 g of γ-conglutin 243 concentrate, α+β+δ-conglutin isolate and ovalbumin supplemented pasta samples were given the 244 animals, which entirely ate them within 30 minutes. Immediately after this meal, blood glucose was 245 determined and 2 g/kg of D-glucose were administered to the animals by gavage. The amount of 246 administered γ-conglutin in this experiment corresponded to about 45 mg/kg body weight. The 247 glycaemia levels every 30 min for two hours of the glucose overload trial are reported in Table 4 . 248
Major changes were observed up to 60 min from the treatment, with statistically significant lower 249 increments for γ-conglutin concentrate supplemented pasta. At 90 minutes all plasma glucose levels 250 reached a maximum and then declined at 2 hours, steadily approaching the basal levels.
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A global estimation of the glycaemia trend is depicted by the incremental areas under the 252 curve (AUC) of the glucose overload trial, reported in Figure 2 . As it can be seen, the plasma 253 glucose reduction by γ-conglutin concentrate was apparent already at the first 30 min, though the 254 differences were not statistically significant. Conversely, large and statistically significant 255 differences were visible at 60 min and up to 90 minutes, where the AUCs induced by γ-conglutin 256 concentrate included in pasta were dramatically lower than those obtained with pasta supplemented 257 with ovalbumin. This finding is consistent with the glucose-lowering activity of lupin γ-conglutin 258
previously measured with the purified protein administered by gavage in rats. 5 However, in the 259 present work the protein was supplemented into a traditional food. 260 261
Discussion 262
In this work, the chronic and acute effects of lupin protein fractions physically entrapped into a 263 common food matrix on selected body parameters and plasma glucose levels of rats was studied. 264
Fasting blood glucose levels were into the same range as reported by previous works focusing on 265 glycemic response to diets with different glycemic index or supplemented with γ-conglutin.
17, 2 An 266 unforeseen finding of this work was the remarkable reduction of food intake and body weight 267 increase induced by pasta supplemented with the lupin protein fractions with respect to the 268 ovalbumin control. Regardless to the hypo-glicaemic activity, that is a peculiar property of γ-269 conglutin 2, 3 , all lupin proteins showed a relevant effect on satiety and weight gain, although the 270 mechanism of action is far from being understood. Although this result is somehow consistent with 271 a former report by Lee et al., 18 who monitored higher satiety and lower energy intake in human 272 subjects fed with lupin enriched bread, the experimental plans of the two works strongly differed, 273 beside being conducted on human subjects and rats. In particular, while these Authors included a 274 lupin kernel flour into bread, thus providing also lupin fibers, of which the satiating role had already 275 been assessed, 19 in our case only purified proteins and at very low dosage were used as supplements. 276 Therefore, although a synergic effect between proteins and fibers could reasonably be expected, in 277 our work the observed differences can be attributed to the protein fraction, only. 278
The further notable finding of this work concerned the decrease of acute glycaemic curve, 279 especially at early times from the initial glucose load, and AUCs specifically induced by γ-conglutin 280 concentrate supplemented pasta. This result confirms previous findings obtained with pure 2, 5 and 281 raw 3 γ-conglutin, thus substantiating its role as plasma glucose-controlling natural agent. However, 282 in the present work the biologically active protein has become a component of a food matrix, while 283 in the previous works it was administered by gavage. Other teams have evidenced glycaemia-284 reducing effects of lupin flours in type II diabetic patients; 20 however, the Authors admitted that 285 their findings could have been affected by the lower carbohydrate content in the lupin meal with 286 respect to the control. Still, pieces of evidence on the specific role played by lupin flours and its 287 components in controlling plasma glucose concentrations are accumulating in the literature.
21,22 288
The long term effect on glycaemia was less evident as compared to a previous work, 5 likely 289 because γ-conglutin intake through the meal was less controlled in this than in that work, where the 290 protein was administered daily by gavage. 291
To the best of our knowledge, this work represents the first report on the effects of a 292 biologically active protein included in a food matrix. Indeed food processes (mechanical forces, 293 high temperatures, pressures, etc.) could influence protein intrinsic properties and affect the 294 interactions with other food components. However, it appears from our results that the physical 295 entrapment of γ-conglutin into pasta matrix has not hampered its biological activity. It can be 296 argued that the resulting diminished accessibility of the lupin protein to gastric enzyme and extreme 297 low pH may have preserved γ-conglutin covalent structure and allowed its transit into duodenum in 298 an intact and active form. As a matter of facts, γ-conglutin was shown to be fully resistant to 299 digestive enzymes with optimum pH at neutral values. 23 In the present study, the heating effect on 300 protein bio-activity could not be evaluated since pasta was administered to the animals without 301 cooking. However, the presence of intact γ-conglutin in brine-cooked seeds has been detected 302 Table 2 The fasting glycaemia and energy metabolism-related hormones levels in rats fed pasta supplemented with lupin γ γ γ γ-conglutin concentrate, α+β+δ α+β+δ α+β+δ α+β+δ-conglutin isolate and ovalbumin for three weeks For each of the three treatments, a separate set of eight rats was used. Data are presented as means ± standard deviation.
Treatment (n=8)
Initial glycaemia (mg/dL)
Final glycaemia (mg/dL) Insulin (ng/mL) Leptin (ng/mL) Ghrelin (ng/mL) CI = Conversion Index (feed/gain) ; ADG = Average Daily Gain * P < 0.05 **P < 0.01 † P = 0.064 Table 4 Glycaemia variations upon glucose overload in hyperglycemic rats fed 10 g pasta supplemented with lupin γ γ γ γ-conglutin concentrate, α+β+δ α+β+δ α+β+δ α+β+δ-conglutin isolate and ovalbumin. For each of the three treatments, a separate set of eight rats was used. Data are expressed as means ± standard deviation. 
Treatment
